Nivolumab in Esophageal Squamous-Cell Carcinoma. Reply

N Engl J Med. 2022 May 19;386(20):1961. doi: 10.1056/NEJMc2202880.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Esophageal Neoplasms* / drug therapy
  • Esophageal Squamous Cell Carcinoma* / drug therapy
  • Esophageal Squamous Cell Carcinoma* / pathology
  • Humans
  • Nivolumab / therapeutic use

Substances

  • Nivolumab